1829 related articles for article (PubMed ID: 25171736)
21. Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.
Zee AA; van Lieshout K; van der Heide M; Janssen L; Janzing HM
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD006681. PubMed ID: 28780771
[TBL] [Abstract][Full Text] [Related]
22. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Robertson L; Yeoh SE; Ramli A
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
[TBL] [Abstract][Full Text] [Related]
23. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
Herlihy DR; Thomas M; Tran QH; Puttaswamy V
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD010525. PubMed ID: 32692430
[TBL] [Abstract][Full Text] [Related]
24. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
25. Treatment for superficial thrombophlebitis of the leg.
Di Nisio M; Wichers IM; Middeldorp S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD004982. PubMed ID: 29478266
[TBL] [Abstract][Full Text] [Related]
26. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
[TBL] [Abstract][Full Text] [Related]
27. Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.
Hakoum MB; Kahale LA; Tsolakian IG; Matar CF; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD006649. PubMed ID: 29363105
[TBL] [Abstract][Full Text] [Related]
28. Anticoagulation for perioperative thromboprophylaxis in people with cancer.
Matar CF; Kahale LA; Hakoum MB; Tsolakian IG; Etxeandia-Ikobaltzeta I; Yosuico VE; Terrenato I; Sperati F; Barba M; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009447. PubMed ID: 29993117
[TBL] [Abstract][Full Text] [Related]
29. Pentasaccharides for the treatment of deep vein thrombosis.
Brandao GM; Junqueira DR; Rollo HA; Sobreira ML
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011782. PubMed ID: 29199766
[TBL] [Abstract][Full Text] [Related]
30. Parenteral anticoagulation in ambulatory patients with cancer.
Akl EA; Kahale LA; Hakoum MB; Matar CF; Sperati F; Barba M; Yosuico VED; Terrenato I; Synnot A; Schünemann H
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD006652. PubMed ID: 28892556
[TBL] [Abstract][Full Text] [Related]
31. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
Andras A; Sala Tenna A; Crawford F
Cochrane Database Syst Rev; 2012 Oct; 10():CD002001. PubMed ID: 23076894
[TBL] [Abstract][Full Text] [Related]
32. Home versus in-patient treatment for deep vein thrombosis.
Othieno R; Okpo E; Forster R
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
[TBL] [Abstract][Full Text] [Related]
33. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
Robertson L; Roche A
Cochrane Database Syst Rev; 2013 Dec; (12):CD010525. PubMed ID: 24343728
[TBL] [Abstract][Full Text] [Related]
34. Treatment for superficial thrombophlebitis of the leg.
Di Nisio M; Wichers IM; Middeldorp S
Cochrane Database Syst Rev; 2013 Apr; (4):CD004982. PubMed ID: 23633322
[TBL] [Abstract][Full Text] [Related]
35. Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Barba M; Yosuico VED; Terrenato I; Sperati F; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD006466. PubMed ID: 29285754
[TBL] [Abstract][Full Text] [Related]
36. Parenteral anticoagulation in ambulatory patients with cancer.
Akl EA; Kahale LA; Ballout RA; Barba M; Yosuico VE; van Doormaal FF; Middeldorp S; Bryant A; Schünemann H
Cochrane Database Syst Rev; 2014 Dec; (12):CD006652. PubMed ID: 25491949
[TBL] [Abstract][Full Text] [Related]
37. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
Akl EA; Kahale L; Neumann I; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD006649. PubMed ID: 24945634
[TBL] [Abstract][Full Text] [Related]
38. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Jones LE
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD001100. PubMed ID: 28182249
[TBL] [Abstract][Full Text] [Related]
39. Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents.
Kahale LA; Matar CF; Tsolakian I; Hakoum MB; Yosuico VE; Terrenato I; Sperati F; Barba M; Hicks LK; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD014739. PubMed ID: 34582035
[TBL] [Abstract][Full Text] [Related]
40. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.
Akl EA; Vasireddi SR; Gunukula S; Barba M; Sperati F; Terrenato I; Muti P; Schünemann H
Cochrane Database Syst Rev; 2011 Jun; (6):CD006649. PubMed ID: 21678360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
